Ig-responsive relapsing inflammatory syndrome following COVID-19 in a kidney transplant recipient

Kidney Int. 2021 Mar;99(3):767-768. doi: 10.1016/j.kint.2020.12.027. Epub 2021 Jan 22.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • COVID-19 / complications*
  • COVID-19 / diagnosis
  • COVID-19 / immunology
  • COVID-19 / virology
  • Dose-Response Relationship, Drug
  • Graft Rejection / immunology
  • Graft Rejection / prevention & control
  • Humans
  • Immunoglobulins, Intravenous / administration & dosage*
  • Immunosuppressive Agents / adverse effects
  • Kidney Transplantation / adverse effects*
  • Male
  • Recurrence
  • SARS-CoV-2 / immunology
  • SARS-CoV-2 / isolation & purification
  • Systemic Inflammatory Response Syndrome / diagnosis
  • Systemic Inflammatory Response Syndrome / drug therapy*
  • Systemic Inflammatory Response Syndrome / immunology
  • Transplant Recipients
  • Treatment Outcome

Substances

  • Immunoglobulins, Intravenous
  • Immunosuppressive Agents